IMGN
(NASDAQ)
3.74
+0.3203  (+8.56%)
Volume (24h): 2.50M Day Range: 3.34 - 3.88
Market Cap: 651.96M 52W Range: 1.76 - 7.07
Mar-15-20 03:30PM Why Is ImmunoGen (IMGN) Down 45.5% Since Last Earnings Report?Zacks
Feb-21-20 03:17PM Edited Transcript of IMGN earnings conference call or presentation 14-Feb-20 1:00pm GMTThomson Reuters StreetEvents
10:44AM Edited Transcript of IMGN earnings conference call or presentation 14-Feb-20 1:00pm GMTThomson Reuters StreetEvents
Feb-18-20 01:35PM Stock Market News for Feb 18, 2020Zacks
04:20AM Edited Transcript of IMGN earnings conference call or presentation 14-Feb-20 1:00pm GMTThomson Reuters StreetEvents
Feb-17-20 11:58PM Edited Transcript of IMGN earnings conference call or presentation 14-Feb-20 1:00pm GMTThomson Reuters StreetEvents
02:41PM ImmunoGen (IMGN) Q4 Earnings & Sales Beat, Shares RallyZacks
Feb-14-20 10:00PM US Indexes Close Mostly Flat Friday With Gains for the WeekGuruFocus.com
12:45PM ImmunoGen (IMGN) Q4 Earnings and Revenues Beat EstimatesZacks
Feb-14-20 11:30AM ImmunoGen Reports Recent Progress and 2019 Financial ResultsBusiness Wire
Feb-07-20 05:30PM Will ImmunoGen (IMGN) Report Negative Earnings Next Week? What You Should KnowZacks
Feb-06-20 09:30PM ImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesBusiness Wire
Feb-03-20 09:30PM ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire
02:50PM Should You Worry About ImmunoGen, Inc.'s (NASDAQ:IMGN) CEO Pay Cheque?Simply Wall St.
Jan-30-20 09:01PM ImmunoGen Announces Conference Call to Discuss Its 2019 Operating ResultsBusiness Wire
Jan-27-20 09:01PM ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesBusiness Wire
Jan-23-20 12:24PM The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus TreatmentBenzinga
01:44AM ImmunoGen Announces Pricing of Public Offering of Common StockBusiness Wire
Jan-22-20 09:01PM ImmunoGen Announces Proposed Public Offering of Common StockBusiness Wire
Jan-03-20 03:46PM ImmunoGen Announces Webcast of Presentation and Q&A at the 38th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
Jan-02-20 01:30PM ImmunoGen Announces Webcast of Presentation and Q&A at the 38th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
Dec-31-19 09:01PM ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire
Dec-24-19 12:12PM ImmunoGen Lead Drug Gets Nod for Accelerated Approval Pathway (Revised)Zacks
Dec-19-19 05:50PM Bed Bath & Beyond and 3 more stocks showing momentumMarketWatch
05:05PM 4 Momentum Stocks To WatchBenzinga
Dec-19-19 02:04PM ImmunoGen (IMGN) Looks Good: Stock Adds 7.6% in SessionZacks
Dec-18-19 01:25PM ImmunoGen Lead Drug Gets Nod for Accelerated Approval PathwayZacks
Dec-17-19 09:00PM ImmunoGen shares rise on ovarian cancer studyMarketWatch
11:30AM ImmunoGen Announces Accelerated Approval Pathway for Mirvetuximab Soravtansine in Ovarian CancerBusiness Wire
Dec-15-19 02:13AM Hedge Funds Are Dumping ImmunoGen, Inc. (IMGN)Insider Monkey
Dec-09-19 08:01PM ImmunoGen Presents Updated Findings from Phase 1 Study of IMGN632 at ASH Annual MeetingBusiness Wire
Dec-01-19 02:30PM ImmunoGen (IMGN) Up 51.7% Since Last Earnings Report: Can It Continue?Zacks
Nov-26-19 09:30PM ImmunoGen Announces Webcast of Presentation at the Piper Jaffray 31st Annual Healthcare ConferenceBusiness Wire
Nov-18-19 02:34PM Roche Gets CHMP Opinion for Breast Cancer & Lymphoma DrugsZacks
Nov-10-19 05:50AM Edited Transcript of IMGN earnings conference call or presentation 1-Nov-19 12:00pm GMTThomson Reuters StreetEvents
01:45AM Edited Transcript of IMGN earnings conference call or presentation 1-Nov-19 12:00pm GMTThomson Reuters StreetEvents
Nov-09-19 01:31AM Edited Transcript of IMGN earnings conference call or presentation 1-Nov-19 12:00pm GMTThomson Reuters StreetEvents
Nov-08-19 09:34PM Edited Transcript of IMGN earnings conference call or presentation 1-Nov-19 12:00pm GMTThomson Reuters StreetEvents
Nov-07-19 07:51PM Is ImmunoGen, Inc. (IMGN) A Good Stock To Buy?Insider Monkey
Nov-06-19 02:01PM ImmunoGen to Present New Data on IMGN632 at 61st ASH Annual MeetingBusiness Wire
Nov-05-19 12:29PM How Many ImmunoGen, Inc. (NASDAQ:IMGN) Shares Do Institutions Own?Simply Wall St.
Nov-04-19 04:54PM ImmunoGen (IMGN) Q3 Earnings & Sales Beat, Shares RallyZacks
02:27PM Company News for Nov 4, 2019Zacks
Nov-01-19 11:45AM ImmunoGen (IMGN) Reports Q3 Loss, Tops Revenue EstimatesZacks
10:30AM ImmunoGen Reports Recent Progress and Third Quarter 2019 Financial ResultsBusiness Wire
Oct-25-19 02:31PM ImmunoGen (IMGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks
Oct-18-19 08:30PM ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2019 Operating ResultsBusiness Wire
Sep-30-19 01:49PM Did ImmunoGen, Inc. (NASDAQ:IMGN) Insiders Buy Up More Shares?Simply Wall St.
Sep-29-19 10:01AM ImmunoGen Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination with Carboplatin and Avastin® at ESMOBusiness Wire
06:31AM ImmunoGen Presents Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer at ESMOBusiness Wire
ImmunoGen, Inc., a clinical-stage biotechnology company, focuses on developing antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; IMGN779 that is in Phase I clinical trial for the treatment of acute myeloid leukemia (AML); and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm, as well as coltuximab ravtansine, a CD19-targeting ADC, which is in Phase II trial for DLBCL. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; CytomX Therapeutics, Inc.; Takeda Pharmaceutical Company Limited; Jazz Pharmaceuticals plc; and Debiopharm International SA. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)